| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |